Galapagos NV is a pioneering biopharmaceutical company based in Mechelen, Belgium, focusing on the discovery, development, and commercialization of innovative medicines for diseases with significant unmet medical needs. Its notable work includes the development of filgotinib, a promising treatment for various inflammatory conditions, and a portfolio of other potential therapies in different stages of clinical trials. Galapagos NV collaborates with leading global pharmaceutical companies like Gilead Sciences, AbbVie, and Novartis to bring groundbreaking treatments to patients worldwide.
Wednesday's top analyst upgrades and downgrades included Alphabet, Facebook, Harley-Davidson, JetBlue Airways, Lowe's Companies, Occidental Petroleum, Overstock.com, Snap and Southwest Airlines.
Tuesday's top analyst upgrades and downgrades included Advance Auto Parts, Dish Network, Intuit, Kroger, Palo Alto Networks, Qorvo, Starbucks and Texas Instruments.
Galapagos was crushed on Wednesday after the firm, in conjunction with Gilead, announced a new commercialization and development agreement for their Rheumatoid Arthritis (RA) treatment.
Tuesday's top analyst upgrades and downgrades included Crocs, Gap, GW Pharmaceuticals, Lowe's Companies, Merck, Nio, Palo Alto Networks, Phillips 66, Starbucks and Vital Farms.
The FDA has come down on an investigational treatment for moderately to severely active from Gilead Sciences and Galapagos.
Monday's top analyst upgrades, downgrades and initiations included Agilent Technologies, Antero Midstream, Chewy, Domino's Pizza, eHealth, First Solar, Kraft Heinz, Newmont, Square, Tilray and Wayfair.
Thursday's top analyst upgrades, downgrades and initiations included Advanced Micro Devices, American Electric Power, Analog Devices, CenturyLink, Dish Network, Herbalife, NextEra Energy, NRG Energy, On Semiconductor and SolarEdge Technologies.
Monday's top analyst upgrades, downgrades and initiations included Alphabet, Apple, Bank of America, Citigroup, Dollar Tree, Nordstrom, Salesforce, Travelers and JD.com.
